Clinical Trial Update: Folate and Protection Against Cervical Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating folate for protection against cervical cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Folate (folic acid)

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Cervical Cancer | Phase 1, Phase 2 | Status: TERMINATED